THAT GOES INTO EFFECT AUGUST 1ST. ALSO NEW AT NOON, THE GOVERNOR OFFICIALLY SIGNING THE BILL INTO LAW JUST ABOUT AN HOUR AND A HALF AGO. ESSENTIALLY ABOLISHING INSPECTION STICKERS FOR MOST LOUISIANA ...

Google Messages is moving closer to completely removing the convenient QR code pairing method for its desktop web app. In the v20260511 beta version of the Android app, the built-in QR code scanner ...

AI has taken the world by storm over the last few years, with millions of users writing prompts on platforms like ChatGPT to generate content, images, and yes videos. Still, some of these platforms ...

AI video generators help you turn your prompts into believable videos, complete with audio. We've tested all the top services to help you choose the one that does the best job with the fewest tweaks.

Today, you can use Google Messages for web using QR code pairing or Google Account sign-in. The original login method will soon go away. Opening messages.google.com ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Engineers have developed an automated microfluidic platform that dramatically accelerates the formulation of lipid nanoparticles, the delivery vehicles behind mRNA vaccines and gene therapies.

AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Generate:Biomedicines has already earmarked $300 million of the IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (jxfzsy/iStock/Getty Images Plus) ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...